SGAM
PBYI icon

Smith Group Asset Management’s Puma Biotechnology PBYI Stock Holding History

Smith Group Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,440
Closed -$203K – 446
2018
Q2 		$203K Buy
3,440
+200
+6% +$11.6K 0.01% 251
2018
Q1 		$220K Sell
3,240
-2,300
-42% -$172K 0.01% 247
2017
Q4 		$548K Hold
5,540
– – 0.02% 200
2017
Q3 		$663K Hold
5,540
– – 0.02% 192
2017
Q2 		$484K Hold
5,540
– – 0.01% 216
2017
Q1 		$206K Hold
5,540
– – 0.01% 268
2016
Q4 		$170K Hold
5,540
– – 0.01% 272
2016
Q3 		$371K Buy
+5,540
New +$280K 0.01% 205

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return